Search
Acute Ulcerative Colitis
go.drugbank.com/conditions/DBCOND0065067Drugs: MesalazineSynonyms: Colitis gravis, Colitis gravis, NOSNitisinone
go.drugbank.com/drugs/DB00348ApprovedIt is sold under the brand names Orfadin and Harliku. [L53253, L53258]
Acetaminophen
go.drugbank.com/drugs/DB00316ApprovedInvestigationalAcetaminophen (paracetamol), also commonly known as Tylenol, is the most commonly taken analgesic worldwide and is recommended as first-line therapy in pain conditions by the World Health Organization (WHO). It is also used for its antip...
Mixtures: DOLO-NEUROBIONProducts: Acetaminophen Oral Soln 80mg/5ml USP, Sol Orale D'acetaminophene 80mg/ml EnfCinacalcet
go.drugbank.com/drugs/DB01012ApprovedInvestigationalCinacalcet is a calcimimetic sold by Amgen under the trade name Sensipar® in North America and Australia and as Mimpara® in Europe.
Chlorothiazide
go.drugbank.com/drugs/DB00880ApprovedInvestigationalVet approvedA thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)
Benziodarone
go.drugbank.com/drugs/DB13277ApprovedWithdrawnBenziodarone is a uricostatic and a uricosuric agent which is sold also under the name Amplivex-Labaz. It is used in the treatment of gout [A175630].
Profenamine
go.drugbank.com/drugs/DB00392ApprovedIt is sold under the trade name Parsitan in Canada.[L46812] In the US, the marketing of profenamine has been discontinued.[L46817]
Diclofenac
go.drugbank.com/drugs/DB00586ApprovedInvestigationalVet approvedDiclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to infl...
Mixtures: DOLO-PANGAVIT, DOLO-NEUROBIONProducts: Diclofenac Sodium Topical Sol, VOLTAREN DOLOAgomelatine
go.drugbank.com/drugs/DB06594ApprovedInvestigationalIt is currently sold in Australia under the Valdoxan trade name. … In 2006 Servier sold the rights to develop Agomelatine in the US to Novartis. The development for the US market was discontinued in October 2011.
Ubidecarenone
go.drugbank.com/drugs/DB09270ApprovedInvestigationalNutraceuticalFDA does not approve this dietary supplements before sold nor regulate the manufacturing process.[L1063] … [L1062] Ubidecarenone is sold as a dietary supplement and is not FDA approved as a drug - it is not meant to treat, cure or prevent any disease.